Capricorn Fund Managers’s Genmab GMAB Stock Holding History

Capricorn Fund Managers’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-37,007	Closed	-$1.31M	–	66
2023 Q3	$1.31M	Buy	+37,007	New	+$1.41M	0.45%	56
2023 Q2	–	Sell	-110,643	Closed	-$4.18M	–	84
2023 Q1	$4.18M	Buy	+110,643	New	+$4.25M	1.28%	26
2022 Q4	–	Sell	-11,768	Closed	-$378K	–	89
2022 Q3	$378K	Sell	11,768 -136,643	-92%	-$4.8M	0.12%	80
2022 Q2	$4.82M	Buy	+148,411	New	+$4.81M	0.88%	26

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capricorn Fund Managers's GMAB Position: Q4 2023 in Review

Capricorn Fund Managers sold out of Genmab (GMAB) in Q4 2023, closing a stake of 37,007 shares — an estimated $1.31M sold.

Capricorn Fund Managers first reported a position in GMAB in Q2 2022 and held it in 4 quarters. The position peaked at $4.82M in Q2 2022. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

Capricorn Fund Managers reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
Capricorn Fund Managers sold 37,007 Genmab shares in Q4 2023, an estimated $1.31M.
Capricorn Fund Managers first reported a position in Genmab in Q2 2022 and held it in 4 quarters.
Capricorn Fund Managers's Genmab position peaked at $4.82M in Q2 2022.
225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Capricorn Fund Managers's 13F filing for Q4 2023, filed 10 Jan 2024.